Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31.3 HKD | +3.47% | -5.88% | -18.83% |
Apr. 26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.83% | 3.36B | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- 9995 Stock
- News RemeGen Co., Ltd.
- UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy